Mato, Anthony R <br/><br/>
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.  [electronic resource] 

 -  Haematologica  09 2018 
 - 1511-1517 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2018.193615  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bridged Bicyclo Compounds, Heterocyclic--administration & dosage<br/>Disease Management<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Sulfonamides--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome<br/>Tumor Lysis Syndrome--etiology